- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.06. | Prenetics posts revenue growth, lifts 2026 outlook | 1 | Seeking Alpha | ||
| 10.06. | Prenetics raises 2026 IM8 revenue guidance on strong growth | 4 | Investing.com | ||
| 10.06. | Prenetics Global Limited: Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue | 766 | GlobeNewswire (Europe) | Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025Raises... ► Artikel lesen | |
| 04.06. | Prenetics Global Limited: Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion | 10 | GlobeNewswire (USA) | ||
| 04.06. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.05. | Prenetics Global Limited: Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership | 6 | GlobeNewswire (USA) | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 14.05. | Prenetics Global Reports Q1 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 14.05. | Prenetics raises 2026 guidance on IM8 supplement growth | 2 | Investing.com | ||
| 14.05. | Prenetics Global Limited: Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 | 378 | GlobeNewswire (Europe) | ~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global... ► Artikel lesen | |
| 14.05. | Prenetics Global reports Q1 results; gives Q2 and raises FY26 outlook | 3 | Seeking Alpha | ||
| 14.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.05. | Prenetics Global Limited: Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership | 2 | GlobeNewswire (USA) | ||
| 04.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14.04. | Prenetics Global Limited: Prenetics' IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One | 5 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics gewinnt NBA-Star Giannis Antetokounmpo als neuen Aktionär und Partner | 5 | Investing.com Deutsch | ||
| 02.04. | Prenetics Global Limited: Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership | 2 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 01.04. | Prenetics Global (PRE) Partners with Superpower on Diagnostics and Supplements | 5 | Insider Monkey | ||
| 24.03. | Prenetics Global Limited: Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation | 3 | GlobeNewswire (USA) | ||
| 06.03. | Prenetics: Aktienrückkaufprogramm über 40 Mio. USD treibt Kurs an | 2 | Investing.com Deutsch |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 540,70 | -0,41 % | Regeneron Pharmaceuticals, Inc.: Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) | Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing FDA accepted NDA under Priority Review with a target... ► Artikel lesen | |
| VIKING THERAPEUTICS | 30,450 | -0,49 % | Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy? | ||
| CANSINO BIOLOGICS | 2,440 | +0,83 % | CanSino Biologics Inc: CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion | HONG KONG, Apr 28, 2026 - (ACN Newswire) - CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled... ► Artikel lesen | |
| GUARDANT HEALTH | 116,28 | +1,15 % | Guardant Health, Inc. - 8-K, Current Report | ||
| SINO BIOPHARM | 0,491 | -1,17 % | Dividendenbekanntmachungen (24.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AH REALTY TRUST INC US04208T1088 0,14 USD 0,1229 EUR AMBEV SA ADR US02319V1035 0,0091 USD 0,008 EUR ARLANDASTAD GROUP AB SE0016276851 1... ► Artikel lesen | |
| BIO-TECHNE | 49,440 | -0,02 % | Is Bio-Techne Stock Underperforming the S&P 500? | ||
| GENSCRIPT BIOTECH | 1,240 | +0,81 % | GenScript Biotech Corporation: GenScript Launches TurboCHO Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class | New kit offers researchers and development teams a meaningful advance in expression speed and output BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch... ► Artikel lesen | |
| INNOVENT BIOLOGICS | 8,515 | +0,90 % | Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma | SAN FRANCISCO and SUZHOU, China, June 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that... ► Artikel lesen | |
| QUANTUM-SI | 0,880 | 0,00 % | Quantum-Si Incorporated: Quantum-Si Announces the Start of the Proteus Roadshow | Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics... ► Artikel lesen | |
| SCILEX | 5,800 | 0,00 % | Scilex (SCLX) Stock Jumps After Dream Bowl Meme Coin Listing Update: Why Is It Moving? | ||
| ORIGIN AGRITECH | 0,830 | -2,35 % | Origin Agritech Limited: Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026 | Net Loss Narrows by 44% Year-Over-Year, Driven by 44% Reduction in Operating Expenses
BEIJING, May 21, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED)... ► Artikel lesen | |
| AKESO | 9,772 | +2,91 % | Akeso, Inc.: Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026 | HONG KONG, June 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 34,140 | -0,06 % | H.C. Wainwright reiterates Harmony Biosciences stock rating at buy | ||
| IMMUNOME | 19,330 | 0,00 % | Immunome Inc. - 8-K, Current Report | ||
| VERA THERAPEUTICS | 38,200 | 0,00 % | Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy | Prescription Drug User Fee Act (PDUFA) date of July 7, 2026 for Biologics License Application (BLA) for accelerated approval of atacicept in patients with IgA Nephropathy (IgAN)Revised ORIGIN 3 eGFR... ► Artikel lesen |
Das Unternehmen PRENETICS GLOBAL LIMITED kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 19,900 Euro und damit -0,10 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.